Home/Cessation Therapeutics/Representative Brett Guthrie

RB

Representative Brett Guthrie

Supporter/Public Advocate, U.S. Congress (R-KY)

Cessation Therapeutics

Therapeutic Areas

Addiction Medicine Overdose Prevention Public Health

Cessation Therapeutics Pipeline

Drug	Indication	Phase
Anti-fentanyl monoclonal antibody (CSX-1004 inferred)	Prevention of fentanyl overdose	Phase 1

Leadership Team at Cessation Therapeutics

Admiral James “Sandy” Winnefeld

Strategic Advisor (Volunteer), USN Retired, Former Vice Chairman of the Joint Chiefs of Staff

Senator Jeanne Shaheen

Supporter/Public Advocate, U.S. Senate (D-NH)

View full Cessation Therapeutics profile